Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier

NCT04662268 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04662268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
November 30, 2020
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic colitis